Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Alcon Research Ltd
Woman and Man Max 99 years
Alcon Research Ltd
Update Il y a 4 ans
Efficacy and Safety of Adding the Brinzolamide/Timolol Maleate Fixed Combination (Azarga®) in Ocular Hypertensive or Glaucoma Patients Uncontrolled on Prostaglandin Monotherapy
The objective of this study is to evaluate the safety and efficacy of adding AZARGA® as a single agent to prostaglandin monotherapy in patients with either ocular hypertension or primary open-angle gl...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Alcon Research Ltd
Update Il y a 4 ans
Comparación de la seguridad y eficacia clínicas de NEVANAC® al 0,1% con el vehículo tras una cirugía de cataratas en pacientes con retinopatía diabética. A Clinical Safety and Efficacy Comparison of NEVANAC® 0.1% to Vehicle following Cataract Surgery in Diabetic Retinopathy Patients
Demonstrate superiority of NEVANAC® (nepafenac ophthalmic suspension) 0.1% relative to nepafenac vehicle based on the percentage of diabetic retinopathy patients who develop macular edema (defined as ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Alcon Research Ltd
Update Il y a 4 ans
Pharmacokinetic and Safety Study of Travoprost 0.004% in Pediatric Glaucoma Patients Estudio de farmacocinética y de seguridad de Travoprost al 0,004% en pacientes pediátricos con glaucoma
To evaluate the steady-state plasma concentrations of Travoprost free acid (AL-5848) following once daily administration of Travoprost Ophthalmic Solution, 0.004% (preserved with POLYQUAD) in pediatri...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Alcon Research Ltd
Update Il y a 4 ans
An Evaluation of the Ocular Surface Health in Subjects Using DUOTRAV APS Ophthalmic Solution Versus XALACOM Ophthalmic Solution
The objective of this study is to demonstrate the superiority of DuoTrav APS over XALACOM in Ocular Surface Disease Index (OSDI) scores in patients with open-angle glaucoma or ocular hypertension.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Alcon Research Ltd
Update Il y a 4 ans
Travoprost MDPF 3 Month Safety and Efficacy Study
To demonstrate that the IOP-lowering efficacy of Travoprost Ophthalmic Solution, 0.004%, MDPF is equivalent to TRAVATAN in patients with open-angle glaucoma or ocular hypertension
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Alcon Research Ltd
Update Il y a 4 ans
Multi-Center Study Assessing Efficacy and Tolerability of TRAVATAN Solution without BAK, containing Polyquad Preservative in Patients Previously on latanoprost or bimatoprost solution Monotherapy. Studio multicentrico che valuta l'efficacia e la tollerabilita' di TRAVATAN Soluzione senza BAK, contenente Conservante Polyquad in pazienti precedentemente trattati con soluzione di latanoprost 0,005 o bimatoprost in monoterapia
to assess the efficacy and tolerability of TRAVATAN Solution without BAK, containing Polyquad Preservative after changing from prior latanoprost 0.005% or bimatoprost 0.01 ophthalmic solution monoth...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Alcon Research Ltd
Update Il y a 4 ans
Comparison of efficacy and tolerability of Travatan and Lumigan in patients with ocular hypertension or glaucoma but who never received any glaucoma drugs
The objective of this study is to assess the efficacy and tolerability of TRAVATAN® Solution without BAK, containing Polyquad® Preservative versus LUMIGAN® 0.01% Solution in treatment naïve patients w...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Alcon Research Ltd
Update Il y a 4 ans
Assessing the Safety and Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% Fixed Combination), as Replacement Therapy in Patients Uncontrolled on Bimatoprost 0.03%/Timolol 0.5% Therapy (Fixed or Unfixed)
The objective of this study is to assess the safety and efficacy of changing to DuoTrav® from prior bimatoprost 0.03% /timolol 0.5% pharmacotherapy in uncontrolled patients with open-angled glaucoma o...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Alcon Research Ltd
Update Il y a 4 ans
Effects of Topical Hypotensive Drugs on Circadian Ocular Perfusion Pressure and Ocular Blood Flow in Patients with Open-Angle Glaucoma
The primary statistical objective of this study is to demonstrate superior effect on diastolic ocular perfusion pressure of AZARGA (Brinzolamide 10 mg/ml/Timolol 5 mg/ml) Eye Drops Suspension relative...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Alcon Research Ltd
Update Il y a 4 ans
Clinical Evaluation of Nepafenac Ophthalmic Suspension, 0.3% for Prevention and Treatment of Ocular Inflammation and Pain after Cataract Surgery
To demonstrate that: 1) Nepafenac Ophthalmic Suspension, 0.3% dosed once daily is not inferior to NEVANAC dosed three times daily for the prevention and treatment of ocular inflammation 14 days after...
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
1
2
3
Next